24097-19-6 Usage
Uses
Used in Pharmaceutical Research and Development:
3-(4-Chlorophenyl)-5-(4-methoxyphenyl)isoxazole is utilized as a compound in pharmaceutical research and development due to its potential pharmacological and biological activities. The presence of the chlorophenyl and methoxyphenyl groups may contribute to its efficacy in targeting specific biological pathways or receptors, making it a promising candidate for the development of new drugs.
Used in Chemical Synthesis:
In the chemical synthesis industry, 3-(4-Chlorophenyl)-5-(4-methoxyphenyl)isoxazole can be used as a building block or intermediate in the synthesis of more complex molecules with potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science.
Used in Biological Research:
3-(4-Chlorophenyl)-5-(4-methoxyphenyl)isoxazole is employed as a research tool in biological studies to investigate its interactions with biological targets and understand its potential effects on cellular processes. This can provide valuable insights into the compound's mechanism of action and its suitability for therapeutic applications.
Note: The specific applications and industries for 3-(4-Chlorophenyl)-5-(4-methoxyphenyl)isoxazole are not explicitly mentioned in the provided materials. The uses listed above are inferred based on the compound's properties and potential activities. Further research and development are necessary to fully explore and validate its applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 24097-19-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,0,9 and 7 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 24097-19:
(7*2)+(6*4)+(5*0)+(4*9)+(3*7)+(2*1)+(1*9)=106
106 % 10 = 6
So 24097-19-6 is a valid CAS Registry Number.
InChI:InChI=1/C16H12ClNO2/c1-19-14-8-4-12(5-9-14)16-10-15(18-20-16)11-2-6-13(17)7-3-11/h2-10H,1H3
24097-19-6Relevant articles and documents
Aerobic oxidative synthesis of 3,5-disubstituted isoxazoles directly from α,β-unsaturated ketones
Li, Zheng,Wen, Gong,Fu, Rugang,Yang, Jingya
, p. 643 - 644 (2016/10/22)
Using an efficient aerobic oxidative method, the synthesis of ten 3,5-disubstituted isoxazoles by treatment of α,β-unsaturated ketones with hydroxylamine and NaOH at room temperature has been achieved.
Efficient and convenient method for the synthesis of isoxazoles in ionic liquid
Valizadeh, Hassan,Amiri, Mohammad,Gholipur, Hamid
experimental part, p. 108 - 110 (2009/05/07)
An efficient one-pot synthesis of 3,5-disubstitueted isoxazoles from β-diketones in room temperature ionic liquids (ILs) is described. Compared with the classical reaction conditions, this new synthetic method is environmentally friendly and has the advan
Convenient synthesis of 3,5-disubstituted isoxazoles
Kurangi, Reshma F.,Kawthankar, Rima,Sawal, Sulfala,Desai, Vidya G.,Tilve, Santosh G.
, p. 587 - 589 (2007/10/03)
α,β-Unsaturated oximes obtained from the corresponding α,β-unsaturated ketones on treatment with 2 equivalents of manganese dioxide in refluxing chloroform gives 3,5-disubstituted isoxazoles in good yields. Copyright Taylor & Francis Group, LLC.
Synthesis and structure-activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists
Weidner-Wells, Michele A.,Henninger, Todd C.,Fraga-Spano, Stephanie A.,Boggs, Christine M.,Matheis, Michele,Ritchie, David M.,Argentieri, Dennis C.,Wachter, Michael P.,Hlasta, Dennis J.
, p. 4307 - 4311 (2007/10/03)
A novel series of 3,5-diarylisoxazole and 3,5-diaryl-1,2,4-oxadiazole IL-8 inhibitors has been identified. These compounds exhibit activity in an IL-8 binding assay as well as in a functional assay of IL-8 induced elastase release from neutrophils. In add
